Multistate analysis from cross‐sectional and auxiliary samples

Epidemiological studies routinely involve cross‐sectional sampling of a population comprised of individuals progressing through life history processes. We consider features of a cross‐sectional sample in terms of the intensity functions of a progressive multistate disease process under stationarity assumptions. The limiting values of estimators for regression coefficients in naive logistic regression models are studied, and simulations confirm the key asymptotic results that are relevant in finite samples. We also consider the need for and the use of data from auxiliary samples, which enable one to fit the full multistate life history process. We conclude with an application to data from a national cross‐sectional sample assessing marker effects on psoriatic arthritis among individuals with psoriasis.

[1]  O. Aalen,et al.  Survival and Event History Analysis: A Process Point of View , 2008 .

[2]  Niels Keiding,et al.  Statistical Models Based on Counting Processes , 1993 .

[3]  Yoosoo Chang,et al.  Risk Factors Associated with Rectal Neuroendocrine Tumors: A Cross-Sectional Study , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[4]  Bryan Langholz,et al.  Case-control studies = odds ratios: blame the retrospective model. , 2010, Epidemiology.

[5]  I. Brandslund,et al.  Genetic polymorphisms associated with psoriasis and development of psoriatic arthritis in patients with psoriasis , 2018, PloS one.

[6]  N. Keiding.  Age–period–cohort analysis in the 1870s: Diagrams, stereograms, and the basic differential equation , 2011 .

[7]  Jinfeng Xu,et al.  Statistical Analysis of Illness–Death Processes and Semicompeting Risks Data , 2010, Biometrics.

[8]  D. Gladman,et al.  Gender-related differences in patients with psoriatic arthritis , 2012 .

[9]  Niels Keiding,et al.  Independent Delayed Entry , 1992 .

[10]  Jing Ning,et al.  Maximum Likelihood Estimations and EM Algorithms With Length-Biased Data , 2011, Journal of the American Statistical Association.

[11]  Joseph E. Cavanaugh,et al.  Handbook of Epidemiology , 2006 .

[12]  D. Brillinger,et al.  The natural variability of vital rates and associated statistics. , 1986, Biometrics.

[13]  Niels Keiding,et al.  Statistical inference in the Lexis diagram , 1990, Philosophical Transactions of the Royal Society of London. Series A: Physical and Engineering Sciences.

[14]  D. Gladman,et al.  Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis , 2010, Annals of the rheumatic diseases.

[15]  A. Barros,et al.  Bmc Medical Research Methodology Open Access Alternatives for Logistic Regression in Cross-sectional Studies: an Empirical Comparison of Models That Directly Estimate the Prevalence Ratio Cox Regressioncross-sectional Studieslogistic Regressionodds Ratiopoisson Regressionprevalence Ratiorobust Varia , 2022 .

[16]  H. White.  Maximum Likelihood Estimation of Misspecified Models , 1982 .

[17]  Chiung-Yu Huang,et al.  Nonparametric estimation for length-biased and right-censored data. , 2011, Biometrika.

[18]  J. Neyman,et al.  A simple stochastic model of recovery, relapse, death and loss of patients. , 1951, Human biology.

[19]  Jan M. Hoem,et al.  Multistate life table methodology: a probabilist critique. , 1982 .

[20]  D. Gladman,et al.  Psoriatic arthritis: epidemiology, clinical features, course, and outcome , 2005, Annals of the rheumatic diseases.

[21]  R. Stern,et al.  Epidemiology of psoriatic arthritis in the population of the United States. , 2005, Journal of the American Academy of Dermatology.

[22]  O. Miettinen,et al.  Estimability and estimation in case-referent studies. , 1976, American journal of epidemiology.

[23]  R. Brinks,et al.  Illness-death model: statistical perspective and differential equations , 2018, Lifetime Data Analysis.

[24]  E. Freeman,et al.  Prevalence and determinants of visual impairment in Canada: cross-sectional data from the Canadian Longitudinal Study on Aging. , 2018, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[25]  P Hougaard,et al.  Multi-state Models: A Review , 1999, Lifetime data analysis.

[26]  J. Lawless,et al.  Multistate Models for the Analysis of Life History Data , 2018 .

[27]  S. Newman,et al.  Prevalence and predictors of depression in elderly Canadians: The Canadian Study of Health and Aging. , 2005, Chronic diseases in Canada.

[28]  D Kriebel,et al.  Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? , 1998, Occupational and environmental medicine.

[29]  Mark Wright,et al.  Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment. , 2006, Journal of clinical epidemiology.

[30]  J. Trussell,et al.  Demographic Applications of Event History Analysis , 1993 .

[31]  W. Lexis,et al.  Einleitung in die Theorie der Bevölkerungsstatistik , 1875 .

[32]  Masoud Asgharian,et al.  Asymptotic behavior of the unconditional NPMLE of the length-biased survivor function from right censored prevalent cohort data , 2005, math/0602239.

[33]  A. Palloni,et al.  Estimation of Health Status Inequalities from Prevalence Data: A Risky Business , 2011 .

[34]  Xiaodong Luo,et al.  Nonparametric estimation for right-censored length-biased data: a pseudo-partial likelihood approach , 2009 .

[35]  Marvin Zelen,et al.  On the theory of screening for chronic diseases , 1969 .

[36]  A. Armstrong,et al.  Psoriasis prevalence among adults in the United States. , 2014, Journal of the American Academy of Dermatology.

[37]  D. Gladman,et al.  Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program. , 2011, Rheumatology.

[38]  W. Eyler,et al.  PSORIATIC ARTHRITIS. , 1965, Henry Ford Hospital medical bulletin.

[39]  Richard J Kryscio,et al.  Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. , 2007, American journal of epidemiology.

[40]  D. Gladman,et al.  Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[41]  S. Newman.  Odds ratio estimation in a steady-state population. , 1988, Journal of clinical epidemiology.

[42]  Niels Keiding,et al.  The Current Duration Approach to Estimating Time to Pregnancy , 2012 .

[43]  R. Winchester,et al.  HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. , 2012, Arthritis and rheumatism.

[44]  C. Salvarani,et al.  Epidemiology of psoriatic arthritis. , 2012, Reumatismo.

[45]  G. Vena,et al.  Gender medicine and psoriasis , 2014 .

[46]  Niels Keiding,et al.  Event history analysis and the cross‐section , 2006, Statistics in medicine.

[47]  J. Alho.  On prevalence, incidence, and duration in general stable populations. , 1992, Biometrics.

[48]  R H Jones,et al.  Multi-state models and diabetic retinopathy. , 1995, Statistics in medicine.

[49]  N. Jewell,et al.  Natural history of diseases: Statistical designs and issues , 2016, Clinical pharmacology and therapeutics.

[50]  Niels Keiding,et al.  Age‐Specific Incidence and Prevalence: A Statistical Perspective , 1991 .

[51]  L. Villa,et al.  Atlas of Sleep Medicine , 1992, Neurology.

[52]  N. Keiding,et al.  Multi-state models for event history analysis , 2002, Statistical methods in medical research.

[53]  Ian Diamond,et al.  The analysis of current status data , 1992 .

[54]  D. Aran,et al.  Premature aging of leukocyte DNA methylation is associated with type 2 diabetes prevalence , 2015, Clinical Epigenetics.

[55]  Richard J. Cook,et al.  Statistical Issues in Modeling Chronic Disease in Cohort Studies , 2014 .

[56]  R. Cook,et al.  The illness-death model for family studies. , 2019, Biostatistics.

[57]  P. Wild.  Design and Planning of Epidemiological Studies , 2005 .

[58]  Peter Lindgren,et al.  Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[59]  R. Winchester,et al.  Epidemiology, genetics and management of psoriatic arthritis 2013: focus on developments of who develops the disease, its clinical features, and emerging treatment options , 2013 .

[60]  H. Kraemer,et al.  How can we learn about developmental processes from cross-sectional studies, or can we? , 2000, The American journal of psychiatry.